Evidence map›Paper›PMID 33493377›Full record

ArticleNeurogastroenterology and motility2021

Factors that contribute to the impairment of quality of life in gastroparesis.

Henry P Parkman, Laura A Wilson, Katherine P Yates, Kenneth L Koch, Thomas L Abell, Richard W McCallum, Irene Sarosiek, Braden Kuo, Zubair Malik, Ron Schey and 8 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Neurogastroenterology and motility, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05846802 (Gastroparesis Registry 4), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05846802 recruitingnot on this mapstarted 2024, after this paper: background citation

Gastroparesis Registry 4 (GpR4): Improving the Understanding of Gastroparesis and Functional Dyspepsia

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2024 to 2027Enrolled250ConditionsGastroparesis, Gastroparesis Nondiabetic, Gastroparesis Due to Diabetes Mellitus Type I, Gastroparesis Due to Diabetes Mellitus Type II
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Scoping review: the social and emotional impacts of gastroparesis.Translational gastroenterology and hepatology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Progress in Gastroparesis - A Narrative Review of the Work of the Gastroparesis Clinical Research Consortium.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 1 country.

Henry P ParkmanTemple University. Philadelphia, PA, USA.ORCID 0000-0003-4904-4891
Laura A WilsonJohns Hopkins University, Baltimore, MD, USA.
Katherine P YatesJohns Hopkins University, Baltimore, MD, USA.
Kenneth L KochWake Forest University, Winston-Salem, NC, USA.ORCID 0000-0002-0074-6553
Thomas L AbellUniversity of Louisville, Louisville, KY, USA.ORCID 0000-0002-3175-5161
Richard W McCallumTexas Tech University Health Sciences Center, El Paso, TX, USA.ORCID 0000-0002-6652-8049
Irene SarosiekTexas Tech University Health Sciences Center, El Paso, TX, USA.ORCID 0000-0003-1678-7269
Braden KuoHarvard Medical School, Boston, MA, USA.ORCID 0000-0002-7228-7317
Zubair MalikTemple University. Philadelphia, PA, USA.
Ron ScheyTemple University. Philadelphia, PA, USA.ORCID 0000-0002-9009-1879
Robert J ShulmanBaylor College of Medicine, Houston, TX, USA.ORCID 0000-0003-2385-0991
Madhusudan GroverMayo Clinic, Rochester, MN, USA.ORCID 0000-0001-5092-0831
Gianrico FarrugiaMayo Clinic, Rochester, MN, USA.
Laura MirielJohns Hopkins University, Baltimore, MD, USA.
James TonasciaJohns Hopkins University, Baltimore, MD, USA.
Frank HamiltonNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
Pankaj J PasrichaJohns Hopkins University, Baltimore, MD, USA.
NIDDK/NIH Clinical Gastroparesis Consortium
Johns Hopkins University · USTemple University · USMayo Clinic in Arizona · USTexas Tech University · USBaylor College of Medicine · USHarvard University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USUniversity of Louisville · USWake Forest University · US

Funding

Gastroparesis Consortium Continuation-Data Coordinating CenterU01DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 2006 to 2015
$17.4M
PGpR2 Year 4 Supplement for the Scientific Data Research Center (SDRC) of the GpCRC 4U24DK074008 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI David M Shade · 2017 to 2026
$11.7M
Subtypes of GastroparesisU01DK073974 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Baharak Moshiree · 2006 to 2026
$7.4M
Temple University Gastroparesis Clinical CenterU01DK073975 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI HENRY PAUL PARKMAN · 2006 to 2026
$7.4M
U of L Clinical Center to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis ConsortiumU01DK074007 · NIDDK · UNIVERSITY OF MISSISSIPPI MED CTR · PI Thomas Lyman Abell · 2006 to 2026
$7.0M
Molecular Approaches to Pathogenesis/Therapy in GastropaU01DK073983 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI PANKAJ J PASRICHA · 2006 to 2026
$6.8M
The GpCRC Pediatric Gastroparesis Registry 2 (PGpR2): Characterization and Clinical Course of Symptoms and Gastric Emptying in Pediatric, Adolescent, and Young Adult Participants with Symptoms of GastU01DK074035 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Irene Sarosiek · 2008 to 2026
$6.7M
Advancing Clinical Science in Pediatric GastroparesisU01DK112194 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Bruno Pedro Chumpitazi, Geoffrey A Preidis · 2016 to 2026
$5.3M
New England Gastropareis Consortium: Neurobiology of GastroparesisU01DK112193 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Helen Burton Murray, Braden Kuo · 2016 to 2026
$4.8M
NIDDK NIH HHS U01 DK073974NIDDK NIH HHS U01 DK073975NIDDK NIH HHS U01 DK073983NIDDK NIH HHS U01 DK074007NIDDK NIH HHS U01 DK074008NIDDK NIH HHS U01 DK074035NIDDK NIH HHS U01 DK112193NIDDK NIH HHS U01 DK112194NIDDK NIH HHS U24 DK074008
6 · The paper itself

Abstract

backgroundUnderstanding factors that impair quality of life (QOL) in gastroparesis is important for clinical management.

aims(a) Determine QOL in patients with gastroparesis; (b) Determine factors that impair QOL.

methodsGastroparetic patientsAQ6 underwent history and questionnaires assessing symptoms (PAGI-SYM and Rome III), QOL (SF-36v2 and PAGI-QOL), depression (Beck Depression Inventory [BDI]), and anxiety (State Trait Anxiety InventoryAQ7). KEY

results715 gastroparesis patients (256 diabetic (DG), 459 idiopathic (IG)) were evaluated. SF-36 physical component (PC) score averaged 33.3 ± 10.5; 41% had impaired score <30. SF-36 PC scores were similar between diabetic and idiopathic gastroparesis. Impaired SF-36 PC associated with increased nausea/vomiting and upper abdominal pain subscores, acute onset of symptoms, higher number of comorbidities, use of narcotic pain medications, and irritable bowel syndrome (IBS). SF-36 mental component (MC) score averaged 38.9 ± 13.0; 26% had impaired score <30. Poor SF-36 MC associated with diabetic etiology, higher Beck depression inventory, and state anxiety scores. PAGI-QOL score averaged 2.6 ± 1.1; 50% had a score of <2.6. Low PAGI-QOL associated with higher fullness, bloating, and upper abdominal pain subscores, more depression and Trait anxiety, smoking cigarettes, need for nutritional support, progressively worsening symptoms and periodic exacerbations. CONCLUSIONS & INFERENCES: Multiple measures show poor QOL present in gastroparesis. Several areas impacted on reduced QOL: (a) Symptoms of nausea, vomiting, and abdominal pain, as well as IBS; (b) Etiology and acute onset and progressively worsening symptoms; (c) Comorbidities and psychological factors such as anxiety and depression; (d) Patient-related factors such as smoking. Targeting the modifiable factors may improve patient outcomes in gastroparesis.

Indexed as

Abdominal PainAdultAnxietyDepressionFemaleGastroparesisHumansMaleMiddle AgedNauseaPsychiatric Status Rating ScalesQuality of LifeSurveys and QuestionnairesVomitingdiabetic gastroparesisgastroparesishealth-related quality of lifeidiopathic gastroparesisquality of life

Identifiers

PMID33493377
PMCPMC8310540
OpenAlexW3122969917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.